The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

those prescribed semaglutide to treat type 2 diabetes – as it was originally intended – are now facing supply issues due to a surge in “off-label” prescriptions for weight loss.

Anesthesiologist Joshua Hackett grew up in Chico, attended Chico State, and now practices in Humboldt County. He has a ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.